Drugs associated with hyperuricemia

  Certain ACEI classes: lenopril, ramipril
  Decrease urate renal clearance
  Hyperuricemia and gout occur at therapeutic doses. In contrast, captopril and enalapril significantly lower serum urate levels, acting like the ARB cloxacin, while other ARBs do not or rarely cause hyperuricemia.
  Diuretics: furosemide, etanercept, hydrochlorothiazide, bumetanide, indapamide, torasemide
  All diuretics: secondary to volume contraction and increased reabsorption of uric acid in the proximal tubule; thiazides: can also completely inhibit proximal tubule secretion
  Increased uric acid influenced by dose and duration of administration
  Pyrazinamide (PZA)
  Drug or its metabolites (e.g., 5 – hydroxypyrazinic acid, a metabolite of PZA) compete with uric acid for organic acid excretion channels, reducing uric acid excretion.
  Daily dosing is more likely to result in hyperuricemia than intermittent dosing. Gout attacks have occurred in patients with a history of gout
  Ethambutol
  Reduces urate renal clearance
  Hyperuricemia and gout occur in most patients on oral doses of 20 mg/(kg・d)
  Cyclosporine A (C s A)
  Reduces urate renal clearance, either through the renal tubular mechanism or by decreasing GFR
  Cyclosporine-induced hyperuricemia, which can cause gout, if the patient has the following risk factors: renal insufficiency, concomitant diuretics and male patients
  Tacrolimus
  Reduction of urate secretion
  niacin
  Occasional hyperuricemia and gout
  Fergusine
  Increases WBC production
  Transient effect, commonly seen with high dose dosing (30-60ug/(kg・d))
  Cytotoxic chemotherapy: adiponectin, asparagine, leucovorin, carboplatin, nitrogen mustard phenylbutyrate, cisplatin, cyclophosphamide, cytarabine, erythromycin, fludarabine, hydroxyurea, nitrogen mustard preparations, mercaptopurine, thioguanine, cetiapide, vincristine
  Rapid cytolysis
  Mainly seen in lymphoma and leukemia treatment, can lead to uric acid nephropathy, acute renal failure
  Aspirin
  Dual effect on uric acid metabolism, inhibiting re-secretion at low doses, causing uric acid retention; at high doses, preventing tubular reabsorption of urate and increasing uric acid excretion
  Dose <2g/d causes hyperuricemia
  Norfloxacin, ciprofloxacin, levofloxacin, etc.
  The mechanism is still unknown, and may be related to the precipitation of crystals in the renal tubules under neutral or alkaline environment, causing renal organic damage and disturbance of renal tubular secretion function.
  Entericase capsule
  Intake of pancreatic enzyme products rich in purine components
  Hyperuricemia, hyperuricuria and uric acid crystalluria can occur at high doses.
  L-dopa
  Inhibits urate secretion
  Patients taking therapeutic doses have a history of hyperuricemia and gout. Second, increased false positives interfere with colorimetric determination of uric acid
  Inosine
  Inosine is a hypoxanthine nucleoside, which is an intermediate product of purine metabolism and is used as an exogenous uric acid precursor to raise uric acid.
  Patients taking >9.6mg/(kg/d) orally will have an increase in uric acid.
  Fructose
  Reduces hepatic ATP synthesis and leads to accelerated uric acid production
  Hyperuricemia is seen after rapid infusion (500mg/h). Avoid use in patients with gout and cirrhosis
  Ethanol
  Can induce impaired glycogen isogenesis, leading to the accumulation of lactic acid and ketone bodies in the body. B C hydroxybutyric acid in lactate and ketone bodies competitively inhibits uric acid excretion.
  Associated with acute gout
  Glucocorticoids
  tumor regression
  Seen when glucocorticoids are used as antineoplastic agents
  Isotretinoin
  vitamin A excess disorder
  hyperuricemia, rare cases of gout
  Viridazole and interferon
  Mechanism unclear; generally associated with hemolysis
  Nephrolithiasis can occur in patients with diabetes mellitus and hypertension; hyperuricemia occurs in approximately 24% of these patients treated with concomitant interferon
  Theophylline
  Interferes with uric acid measurement
  False positive elevation
  Nicergoline
  No correlation with dose and duration of administration
  Sulfonylureas such as glibenclamide, glimepiride, and gliclazide
  Long-term use can affect renal function, reduce uric acid excretion, and increase blood uric acid.